Prostate Cancer Market Research Reports

Prostate Cancer Market Research

Incidences of cancer afflictions have rapidly increased in recent years, while efforts are still underway to find an effective treatment for this disease.

Research reveals that the prostate cancer market is expected to show high growth till 2015. As per research estimates, the global prostate cancer market was valued at $5.4 billion in 2009 and is forecast to further increase at a compound annual growth rate (CAGR) of 6% to reach $7.8 billion by 2015. This high growth forecast is believed to be mainly due to the strong pipeline landscape with innovative drugs and also owing to the high population growth.

The Prostate Cancer drug therapy market research report provides insight into the pipeline status of prostate cancer therapeutics by company and by stage, as well as a summary of the latest news and developments in this area. In addition to new developments and disease specific pipeline projects, the listed reports also contain extensive information in tabular format on a company’s full product pipeline, and products by phase of development with regard to the therapy area. The study also helps in keeping track of the industry-specific competitors and partners by better understanding their product pipeline.

The study basically aims at providing a comprehensive overview of the on-goings of the prostate cancer drugs & therapy market.

 



 

View More
TITLE Actions
Global Prostate Cancer Biomarker Market Size, Status and Forecast 2019-2025
Published in Jan 2019 | US $ 3900 Onwards | By QYResearch Group

Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system. The prostate cancer biomarker market is expected to witness a fast growth owing to rising prevalence of prostate cancer. In 2018, the...

Global Prostate Cancer Screening Market Size, Status and Forecast 2019-2025
Published in Jan 2019 | US $ 3900 Onwards | By QYResearch Group

Prostate cancer screening is the screening process used to detect undiagnosed prostate cancer in those without signs or symptoms. The digital rectal examination is one screening tool during which the prostate is assessed manually through the w...

Global Prostate Cancer Devices Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
Published in Jan 2019 | US $ 3480 Onwards | By Global Info Research

In this report, the research team studied the high intensity focused ultrasound (HIFU), cryotherapy, brachytherapy, and external beam radiation. HIFU is a treatment that using high frequency ultrasound waves concentrated on body tissues, those...

Global Hormone Refractory Prostate Cancer (HRPCA) Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
Published in Jan 2019 | US $ 3480 Onwards | By Global Info Research

Hormone Refractory Prostate Cancer (HRPCA) or Castrate-Resistant Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after having hormonal therapy, is now under the spotlight in prostate cancer market. Due to the high unmet clinic...

Prostate cancer - Epidemiology Forecast to 2028
Published in Jan 2019 | US $ 3250 Onwards | By Delve Insight

DelveInsight's "Prostate cancer - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Prostate cancer epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028. ...

Prostate cancer - Market Insight, Epidemiology and Market Forecast - 2028
Published in Jan 2019 | US $ 6250 Onwards | By Delve Insight

DelveInsight's "Prostate cancer - Market Insight, Epidemiology and Market Forecast - 2028" report provides a detailed analysis of the Prostate cancer epidemiology and market outlook for the 7MM. Markets Covered - United States...

Metastatic Hormone Refractory Prostate Cancer - Pipeline Insight, 2019
Published in Jan 2019 | US $ 1500 Onwards | By Delve Insight

"Metastatic Hormone Refractory Prostate Cancer - Pipeline Insight, 2019” report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Metastatic Hormone Refractory Prostate ...

Metastatic Hormone Refractory Prostate Cancer - Epidemiology Forecast to 2028
Published in Jan 2019 | US $ 3250 Onwards | By Delve Insight

DelveInsight's "Metastatic Hormone Refractory Prostate Cancer - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Metastatic Hormone Refractory Prostate Cancer epidemiology, providing the historical and forecasted data for ...

Metastatic Prostate Cancer - Epidemiology Forecast to 2028
Published in Jan 2019 | US $ 3250 Onwards | By Delve Insight

DelveInsight's "Metastatic Prostate Cancer - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Metastatic Prostate Cancer epidemiology, providing the historical and forecasted data for the 7MM during the forecast period fro...

Metastatic Hormone Refractory Prostate Cancer - Market Insight, Epidemiology and Market Forecast - 2028
Published in Jan 2019 | US $ 6250 Onwards | By Delve Insight

DelveInsight's "Metastatic Hormone Refractory Prostate Cancer - Market Insight, Epidemiology and Market Forecast - 2028" report provides a detailed analysis of the Metastatic Hormone Refractory Prostate Cancer epidemiology and market outlook for the ...

Metastatic Prostate Cancer - Market Insight, Epidemiology and Market Forecast - 2028
Published in Jan 2019 | US $ 6250 Onwards | By Delve Insight

DelveInsight's "Metastatic Prostate Cancer - Market Insight, Epidemiology and Market Forecast - 2028" report provides a detailed analysis of the Metastatic Prostate Cancer epidemiology and market outlook for the 7MM. Markets Covered...

Global and Chinese Prostate Cancer Diagnosis and Treatment Industry, 2018 Market Research Report
Published in Jan 2019 | US $ 3000 Onwards | By Prof Research

The 'Global and Chinese Prostate Cancer Diagnosis and Treatment Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Prostate Cancer Diagnosis and Treatment industry with a focus on the C...

Metastatic Hormone Refractory Prostate Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019
Published in Jan 2019 | US $ 2000 Onwards | By Delve Insight

Introduction DelveInsight's, “Metastatic Hormone Refractory Prostate Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019" report provides comprehensive insights about marketed and Phase III products for Metastatic H...

Metastatic Prostate Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019
Published in Jan 2019 | US $ 2000 Onwards | By Delve Insight

Introduction DelveInsight's, “Metastatic Prostate Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019" report provides comprehensive insights about marketed and Phase III products for Metastatic Prostate Cancer . Th...

Global Hormone Refractory Prostate Cancer Market Size, Status and Forecast 2019-2025
Published in Jan 2019 | US $ 3900 Onwards | By QYResearch Group

Hormone Refractory Prostate Cancer (HRPCA) or Castrate-Resistant Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after having hormonal therapy, is now under the spotlight in prostate cancer market. Due to the high unmet clinic...

Global Castration Resistant Prostate Cancer Treatment Market Size, Status and Forecast 2019-2025
Published in Jan 2019 | US $ 3900 Onwards | By QYResearch Group

Prostate cancer can be defined as it is a form of cancer that develops into male reproductive system. Most of the prostate cancer are slow growing and stable but sometimes it can spread from prostate (gland) to other part of body such as bone and lym...

Global Prostate Cancer Therapeutics Drugs Market Size, Status and Forecast 2019-2025
Published in Jan 2019 | US $ 3900 Onwards | By QYResearch Group

In 2018, the global Prostate Cancer Therapeutics Drugs market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Prostate Cancer Therapeut...

Global and Chinese Prostate Cancer Treatment Industry, 2018 Market Research Report
Published in Jan 2019 | US $ 3000 Onwards | By Prof Research

The 'Global and Chinese Prostate Cancer Treatment Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Prostate Cancer Treatment industry with a focus on the Chinese market. The report pr...

Global Prostate Cancer Testing Market Size, Status and Forecast 2019-2025
Published in Jan 2019 | US $ 3900 Onwards | By QYResearch Group

Prostate cancer testing refers to the tests conducted for the detection, localization, grading, and staging of prostate carcinoma. The currently established methods of prostate cancer detection include digital rectal examination (DRE), serum prostate...

Global and Chinese Castration Resistant Prostate Cancer Crpc Hrpca Therapeutics Industry, 2018 Market Research Report
Published in Jan 2019 | US $ 3000 Onwards | By Prof Research

The 'Global and Chinese Castration Resistant Prostate Cancer Crpc Hrpca Therapeutics Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Castration Resistant Prostate Cancer Crpc Hrpca T...

We are on:

Need Help?